Work

Cardiotoxicity Following Cancer Treatment.

Year: 2017

Type: article

Abstract: More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.

Source: PubMed Central

Authors: G M Walls, A R Lyon, M T Harbinson, G G Hanna

Institutions: Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, National Institute for Health and Care Research, Royal Brompton Hospital, NIHR Royal Brompton Cardiovascular Biomedical Research Unit, Imperial College London, Queen's University Belfast

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2774199419

FWCI: 1.665

Cites: 51

Cited by: 16

Related to: 10